Journal of Glycomics & Lipidomics
Open Access

Oligosaccharides as Anti-Adhesive Agents Against Pathogenic Bacteria

Leila Osman^{* *}Correspondence: Leila Osman, Department of Food Microbiology and Biotechnology, Middle Eastern Center for Functional Food Research, Amman, Jordan, Email:

Author info »

Description

Oligosaccharides are short-chain carbohydrates composed of three to ten monosaccharide units that have garnered significant attention for their functional roles in human health. Beyond their nutritional benefits, these compounds exhibit potent bioactive properties, including prebiotic activity, immunomodulation and antimicrobial effects. One of the emerging applications of oligosaccharides is their role as anti-adhesive agents against pathogenic bacteria. Bacterial adhesion to host tissues is the initial and major step in the establishment of infections, as it allows pathogens to colonize, evade host defenses and initiate disease. By interfering with this process, oligosaccharides prevent bacterial attachment, reduce infection rates and offer a promising non-antibiotic strategy for managing microbial infections.

Pathogenic bacteria, including Escherichia coli, Salmonella, Vibrio cholerae and Helicobacter pylori, adhere to host cells through specific interactions between bacterial adhesins and carbohydrate receptors present on the surface of epithelial cells. Oligosaccharides, due to their structural similarity to these carbohydrate receptors, act as soluble receptor analogues. By mimicking host cell surface glycans, oligosaccharides competitively bind to bacterial adhesins, thereby blocking the attachment of pathogens to epithelial surfaces. This anti-adhesive mechanism disrupts the colonization process and limits bacterial proliferation, reducing the severity of infection without exerting selective pressure for antibiotic resistance.

Human milk oligosaccharides are among the most studied examples of anti-adhesive compounds. These complex oligosaccharides, abundant in breast milk, contribute to the protection of infants from gastrointestinal and respiratory infections. Studies have shown that specific fucosylated and sialylated oligosaccharides inhibit the binding of Escherichia coli, Campylobacter jejuni and rotaviruses to intestinal epithelial cells. The protective effect is attributed to their ability to act as decoy receptors, preventing pathogen adhesion and subsequent invasion. Such findings highlight the potential of oligosaccharides as natural antimicrobial agents with therapeutic and prophylactic applications.

In addition to human milk, oligosaccharides derived from plant and microbial sources have demonstrated anti-adhesive activity. Fructooligosaccharides, galactooligosaccharides and xylo-oligosaccharides, commonly obtained from fruits, vegetables, legumes and agricultural byproducts, have been shown to inhibit pathogen adhesion in vitro. These oligosaccharides modulate the gut microbiota by promoting the growth of beneficial bacteria such as Bifidobacterium and Lactobacillus species. The competitive colonization by beneficial bacteria further prevents pathogen adhesion through nutrient competition, production of antimicrobial metabolites and strengthening of the gut barrier. Therefore, oligosaccharides provide a dual protective effect by directly interfering with pathogen attachment and indirectly supporting a healthy microbial ecosystem.

The efficacy of oligosaccharides as anti-adhesive agents depends on their structural characteristics, including monosaccharide composition, linkage type, degree of polymerization and branching. Fucosylation and sialylation, in particular, enhance the binding affinity of oligosaccharides to bacterial adhesins. Advances in enzymatic synthesis, microbial fermentation and extraction technologies allow the production of structurally defined oligosaccharides with high purity and targeted functionality. These advances enable the development of tailored oligosaccharide-based therapeutics that can prevent specific bacterial infections or support immune health.

The application of oligosaccharides as anti-adhesive agents extends beyond gastrointestinal infections. Research has demonstrated that these compounds can inhibit bacterial adhesion to urinary tract epithelial cells, respiratory tract tissues and dental surfaces, providing preventive strategies against urinary tract infections, respiratory infections and dental caries. For example, cranberry-derived oligosaccharides prevent the adhesion of uropathogenic Escherichia coli to bladder cells, reducing the incidence of urinary tract infections. Similarly, oligosaccharide-enriched functional foods and supplements are being explored for their ability to reduce pathogen colonization in vulnerable populations, such as infants, the elderly and immunocompromised individuals.

The use of oligosaccharides as anti-adhesive agents offers several advantages over traditional antibiotics. They do not kill bacteria directly but inhibit colonization, which reduces selective pressure for the development of resistance. They are biocompatible, non-toxic and can be incorporated into functional foods, nutraceuticals and pharmaceutical formulations. Moreover, their synergistic effects with probiotics and other bioactive compounds enhance their efficacy in preventing infections. However, challenges remain, including optimizing production methods, improving bioavailability and understanding interactions with host tissues and microbiota. Continued research is essential to translate laboratory findings into clinical applications and develop cost-effective, scalable oligosaccharide-based interventions.

In conclusion, oligosaccharides represent a promising class of bioactive compounds that function as anti-adhesive agents against pathogenic bacteria. By mimicking host cell surface glycans, they block bacterial adhesion, prevent colonization and reduce infection risk. Their structural diversity, combined with their ability to modulate gut microbiota and support host immunity, makes them valuable tools for infection prevention and therapeutic development. The sustainable production, structural optimization and incorporation of oligosaccharides into functional foods and pharmaceuticals offer significant potential for managing bacterial infections, reducing reliance on antibiotics and promoting human health.